Neuroscience
Lumosity to Pay $2 Million to Settle FTC Deceptive Advertising Charges for Its “Brain Training” Program
Company Claimed Program Would Sharpen Performance in Everyday Life and Protect Against Cognitive Decline
For Release
January 5, 2016
- News From The World Of Snake Oil
$150 million slap: Laguna Beach firms, parent company fined for false advertising of Procera AVH dietary supplement The Orange County Register 6th July, 2015 Read full article here[snip] The Federal Trade Commission has issued a judgment of more than...
- Alzheimer's Disease: Negative Bapineuzumab Findings In Phase Iii Trial
Critical reading for those interested in Alzheimer's clinical trials: first results from the BAP Phase III program. The link includes additional links to a New York Times article and a company press release. From FierceBiotech: UPDATED: Pfizer, J&J...
- "care Innovations"- A New Joint Ge-intel Project
An Intel press release on the 3rd of January: Read press release According the the press release, "Care Innovations will develop technologies that support healthy, independent living at home and in senior housing communities."...
- Brain Game: Lumosity Games
The Telegraph has a link to a series of Lumosity games: Available here...
- More On The Active Study
From an NIH press release: EMBARGOED FOR RELEASE Tuesday, December 19, 2006 4:00 PM ET NIA CONTACT: Susan Farrer or Linda Joy 301- 496-1752 NINR CONTACT: Lanny Newman 301-496-0209 Mental Exercise Helps Maintain Some Seniors’ Thinking Skills Certain...
Neuroscience
Lumosity Settles with US Federal Trade Commission
Lumosity to Pay $2 Million to Settle FTC Deceptive Advertising Charges for Its “Brain Training” Program
Company Claimed Program Would Sharpen Performance in Everyday Life and Protect Against Cognitive Decline
For Release
January 5, 2016
FTC Press Release
Case Timeline here
- News From The World Of Snake Oil
$150 million slap: Laguna Beach firms, parent company fined for false advertising of Procera AVH dietary supplement The Orange County Register 6th July, 2015 Read full article here[snip] The Federal Trade Commission has issued a judgment of more than...
- Alzheimer's Disease: Negative Bapineuzumab Findings In Phase Iii Trial
Critical reading for those interested in Alzheimer's clinical trials: first results from the BAP Phase III program. The link includes additional links to a New York Times article and a company press release. From FierceBiotech: UPDATED: Pfizer, J&J...
- "care Innovations"- A New Joint Ge-intel Project
An Intel press release on the 3rd of January: Read press release According the the press release, "Care Innovations will develop technologies that support healthy, independent living at home and in senior housing communities."...
- Brain Game: Lumosity Games
The Telegraph has a link to a series of Lumosity games: Available here...
- More On The Active Study
From an NIH press release: EMBARGOED FOR RELEASE Tuesday, December 19, 2006 4:00 PM ET NIA CONTACT: Susan Farrer or Linda Joy 301- 496-1752 NINR CONTACT: Lanny Newman 301-496-0209 Mental Exercise Helps Maintain Some Seniors’ Thinking Skills Certain...